AMPEL BioSolutions Company

AMPEL is a precision medicine company commercializing LDTs that predict disease status, molecular pathways, and best drug options.
Technology: Data-driven Technologies
Industry: Clinical Development, PharmTech
Headquarters: Charlottesville, Virginia, United States
Founded Date: 2013-07-13
Employees Number: 11-50
Funding Status: Seed
Investors Number: 1
Total Funding: 12510000
Estimated Revenue: $1M to $10M
Last Funding Date: 2022-12-13
Last Funding Type: Debt Financing

Visit Website
amriegrammer@ampelbiosolutions.com
https://@AmrieAMPEL
Register and Claim Ownership